ERG and CD31 expression in acute megakaryoblastic leukemia and myeloid sarcoma: A diagnostic pitfall
Authors:
- Ali Yılmaz AltayAAAli Yılmaz Altay
- Naciye Betül BarutNBNaciye Betül Barut
- Simge ErdemSESimge Erdem
- Gülçin YegenGYGülçin Yegen
- 24 August 2026
- journal article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 85
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Endothelial heterogeneity in bone marrow: insights across development, adult life and leukemiaLeukemia, 2024
- Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2023
- Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosisHuman Pathology, 2022
- Myeloid sarcoma with megakaryoblastic differentiation presenting as a breast massHematology/Oncology and Stem Cell Therapy, 2018
- Specification and function of hemogenic endothelium during embryogenesisCellular and Molecular Life Sciences, 2016
- Expression of CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms.JAMA Dermatology, 2014
- CD31 expression in plasmacytic/plasmablastic lesionsAnnals of Diagnostic Pathology, 2013
- Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineageProceedings of the National Academy of Sciences, 2009
- CD31 Expression in Intratumoral MacrophagesAmerican Journal of Surgical Pathology, 2001
- Acute Megakaryoblastic Leukemia in Infants with t(1;22)(p13;q13) AbnormalityAmerican Journal of Clinical Pathology, 1992